We discuss how ZOLGENSMA could be more cost-effective than Spinraza. Also, Kevin Schaefer discusses an article that he wrote for the SMA News Today website regarding how much each of us have changed over the past 10 years.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
This website doesn't track the visitors or use any cookies. Made by Alex Barredo. Send your feedback to alex@barredo.es.
